Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC

Summary: Host: Heather Wakelee, MD, FASCO <br> Guest: Lyudmila Bazhenova, MD <br> <p>We now have FDA approved targeted therapies to treat NSCLC with EGFR exon 20 insertion mutations. Drs. Wakelee and Bazhenova discuss the most current data on both approved therapies and drugs in development.</p>